Orasure Technologies Inc

OraSure Technologies, Inc. (Nasdaq: OSUR) is a diagnostics and sample management company that develops, manufactures, and distributes rapid diagnostic tests and sample collection and stabilization devices. The company operates through its Diagnostics segment, offering point-of-need and home-use rapid tests for conditions including HIV, HCV, syphilis, Ebola, sickle cell disease, and COVID-19, and through its Sample Management Solutions segment via its subsidiary DNA Genotek Inc., providing devices for biological sample collection and stabilization used in research and clinical applications. OraSure also owns Sherlock Biosciences, Inc., a molecular diagnostics platform company developing the InteliQuick CT/NG self-test, and BioMedomics, Inc., which contributes the Sickle SCAN rapid test. Products are sold globally to clinical laboratories, hospitals, physicians' offices, public health organizations, research institutions, government agencies, pharmaceutical companies, and directly to consumers. The company's strategy centers on decentralizing diagnostics to make healthcare more accessible, convenient, and affordable. Updated Aug 5, 2026